Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Resverlogix Corp T.RVX

Alternate Symbol(s):  RVXCF

Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the treatment of cardiovascular disease and associated comorbidities, and post-COVID-19 conditions. RVX-208 is a small molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. RVX-208 is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. It partners with EVERSANA, to support the commercialization of RVX-208 for cardiovascular disease, post-COVID-19 conditions, and pulmonary arterial hypertension in Canada and the United States.


TSX:RVX - Post by User

Bullboard Posts
Comment by toinv261on Jun 24, 2015 3:10pm
125 Views
Post# 23864731

RE:RE:RE:RE:RE:Still no confidence EOM

RE:RE:RE:RE:RE:Still no confidence EOMcoming coming GV. Thanks for your comment but no need to worry. You are obviously a good person. I have no concern whatever about prince's pointless dribble. It is completely meaningless and I do feel some pity for him.

That being said he made 4 important points in his 9:20 post today and I agree with these points.

That would be an ideal world. However the progress RVX has made over many years is exceptional and the rate of progress is exceptional. The approval of the first stage of the BETonMACE phase lll trial in Europe is very significant. Hepalink will be approved as will phase lll in China and other territories.

I don't try to predict where the stock will go. I'm long because I believe that success is close and I know how big the market(s) are for rvx-208.

So everybody needs to make their own choices. GLTA
Cheers
Toinv    :) 
Bullboard Posts